Home›People›Robert Swoboda
Robert Swoboda

Robert Swoboda

Chief Operating Officer at Amani Therapeutics.

Executive
Updated Nov 9, 2026·Latest SEC filing Oct 1, 2026·Suggest an edit

About Robert Swoboda

Robert Swoboda is a chief operating officer at Amani Therapeutics.

Experience

This experience comes from Robert Swoboda's profile and from SEC filings. For roles taken from filings, the years are when the filings name Robert Swoboda in the role, so the role may have started earlier or lasted longer.

Amani Therapeutics, Inc. Current
Chief Operating Officer
2025 – Present · New York, NY
Develops medicines for people with serious psychiatric disorders.
NexTurn BioPharma Advisors LLC
Founder & Consultant
2025 – 2026
Karuna Therapeutics
Senior Vice President, Corporate and Portfolio Operations & Karuna Site Lead
2021 – 2025
bluebird bio
Vice President, SGD Portfolio & Program Management (PPM)
2016 – 2021
Vertex Pharmaceuticals
Senior Director, Cystic Fibrosis Portfolio Management
2014 – 2016
Emmanuel College
Adjunct Faculty Member, Office of Graduate and Professional Programs
2012 – 2014
Penwest Pharmaceuticals
Project Manager
2002 – 2009

Key Colleagues at Startups

The people Robert Swoboda works with at each company, as listed on that company's latest Form D.

Amani Therapeutics, Inc. · Form D, Oct 1, 2026
AL
Alice Lee
Executive officer
RL
-- RTW Holdings VI, LLC
Promoter
LC
Lauren Cuje
Director
PF
Peter Fong
Director
CW

Sources

  1. SECAmani Therapeutics, Inc. Form D, filed Oct 1, 2026